Condition: Erosive Esophagitis · Heartburn · Symptomatic Non-erosive Gastroesophageal Reflux Disease · Sponsor: Phathom Pharmaceuticals, Inc.
The main objective of the study is to compare the maternal, fetal, and infant outcomes of pregnant women who are exposed to vonoprazan during pregnancy with outcomes of an internal comparison cohort of pregnant women who are unexposed to vonoprazan during pregnancy but who may be exposed to other products for the treatment of conditions for which vonoprazan may be prescribed.
This description comes directly from the study's public registry record.
VOQUEZNA Pregnancy Registry · 1-866-609-1612 · DLVOQUEZNAPregnancyRegistry@ppd.com
Always discuss trial participation with your own doctor first.
| PPD | Wilmington, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06660342